triclabendazole 250 MG Oral Tablet [Egaten]
- RxCUI
- 2118612
- RxNorm name
- triclabendazole 250 MG Oral Tablet [Egaten]
- Display name
- triclabendazole 250 MG Oral Tablet [Egaten]
- Full name
- triclabendazole 250 MG Oral Tablet [Egaten]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:59
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EGATEN | TRICLABENDAZOLE | Novartis Pharmaceuticals Corporation | 5552884e-10ea-450c-9658-d3d4f33c946e | 2026-06-04 | Warnings, Adverse reactions | 2118612 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 5552884e-10ea-450c-9658-d3d4f33c946e | triclabendazole 250 MG Oral Tablet [Egaten] | SBD | 11 | These highlights do not include all the information needed to use EGATEN safely and effectively. See full prescribing information for EGATEN. EGATEN ® (triclabendazole) tablets, for oral use Initial U.S. Approval: 2019 | 20250305 |
| 5552884e-10ea-450c-9658-d3d4f33c946e | Egaten 250 MG Oral Tablet | PSN | 11 | These highlights do not include all the information needed to use EGATEN safely and effectively. See full prescribing information for EGATEN. EGATEN ® (triclabendazole) tablets, for oral use Initial U.S. Approval: 2019 | 20250305 |
| 5552884e-10ea-450c-9658-d3d4f33c946e | Egaten 250 MG Oral Tablet | SY | 11 | These highlights do not include all the information needed to use EGATEN safely and effectively. See full prescribing information for EGATEN. EGATEN ® (triclabendazole) tablets, for oral use Initial U.S. Approval: 2019 | 20250305 |